The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1388
ISSUE1388
April 16, 2012
Tafluprost (Zioptan) - A New Topical Prostaglandin for Glaucoma
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Tafluprost (Zioptan) - A New Topical Prostaglandin for Glaucoma
April 16, 2012 (Issue: 1388)
The FDA has approved tafluprost ophthalmic solution
(Zioptan – Merck), a prostaglandin analog, for reduction
of intraocular pressure in patients with open-angle glaucoma
or ocular hypertension. It is being marketed as the
first...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.